title: Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives.
abstract: BACKGROUND
  Overproduction of beta-chemokines and genetic variations in chemokine receptors have been correlated with protection against infection by HIV-1 or slow progression to AIDS in infected individuals.
  
  
  METHODS
  The protective role of chemokines and their receptors was evaluated in a group of seven uninfected (seronegative) hemophiliacs transfused with hemoderivatives presumably contaminated with HIV-1. This group was compared to a group of seven infected (seropositive) hemophiliacs and a group of healthy donors (controls). The CD4+ cell count, intracellular cytokine levels, beta-chemokine levels in plasma, beta-chemokine production by PBMNCs, and expression of chemokine receptors CCR5 and CXCR4 in CD4+ cells were evaluated. The occurrence of protective genotypes in CCR5, CCR2b, and SDF-1 (stromal cell-derived factor 1) genes and susceptibility to infection by HIV-1 were also studied.
  
  
  RESULTS
  Significant differences in the production and plasma levels of beta-chemokines among the three groups were not detected. Lower IL-2 and IFN-gamma production was observed in the uninfected exposed hemophiliacs than in the controls. Genetic analysis of CCR5, CCR2b, and SDF-1 showed several polymorphisms associated with resistance in some HIV-exposed uninfected hemophiliacs. However, these genetic features cannot explain the protection of all exposed hemophiliacs. In fact, only one patient, carrying two copies of CCR5 from which 32 bp was deleted, showed low CCR5 expression and low susceptibility to infection by a CCR5-using HIV-1 strain. In contrast, PBMNCs from all other individuals supported infection in vitro by both CCR5- and CXCR4-using HIV-1 strains.
  
  
  CONCLUSIONS
  It is not possible to assign to beta-chemo-kines and polymorphisms in chemokine receptors a central role in preventing HIV-1 infection. Natural protection against HIV-1 infection is likely to be due to a multiplicity of factors.
authors.affiliation: AIDS Research Institute Caixa (irsiCaixa), Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Barretina
authors.forename: J
authors.initials: J
authors.lastname: Blanco
authors.forename: A
authors.initials: A
authors.lastname: Gutiérrez
authors.forename: L
authors.initials: L
authors.lastname: Puig
authors.forename: C
authors.initials: C
authors.lastname: Altisent
authors.forename: T
authors.initials: T
authors.lastname: Espanol
authors.forename: I
authors.initials: I
authors.lastname: Caragol
authors.forename: B
authors.initials: B
authors.lastname: Clotet
authors.forename: J A
authors.initials: JA
authors.lastname: Esté
mesh_terms: D019742:Chemokines, CC / Q000502:physiology*; D005069:Evaluation Studies as Topic; D015658:HIV Infections / Q000097:blood / Q000517:prevention & control*; D015497:HIV-1; D006467:Hemophilia A / Q000097:blood* / Q000821:virology; D006801:Humans
chemical_list: D019742:Chemokines, CC